Front Psychiatry. 2018 Sep 28;9:464. doi: 10.3389/fpsyt.2018.00464. eCollection 2018.
Frontiers in psychiatry
Roberta Agabio, Lorenzo Leggio
PMID: 30323774 PMCID: PMC6172346 DOI: 10.3389/fpsyt.2018.00464
A limited number of medications are approved to treat Alcohol Use Disorder (AUD). Furthermore, the magnitude of their therapeutic effect is relatively modest, suggesting the potential for subtypes of patients who respond to a specific medication. The use of these medications is also limited in clinical practice by a series of contraindications such as medical comorbidities and/or concurrent use of other medications. In recent years, animal and human studies have been conducted to evaluate the efficacy of baclofen, a GABA
Keywords: GABAB; alcohol use disorder; anxiety; baclofen; mental health disorders; mood disorders